Clinical Trial Update: Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa trial evaluating AllerT versus placebo for birch pollen-induced allergic rhinitis has been terminated. No efficacy or safety results are provided in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• AllerT

Snippet

Sponsor: Anergis | Conditions: Allergic Rhinitis, Allergy | Phase 1, Phase 2 | Status: TERMINATED